Notices. Notice
438 words·~2 min read·
/register/2018/06/19/2018-13098·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4184-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket Nos. FDA-2013-N-0545; FDA-2013-N-0878; FDA-2014-N-0998; FDA-2014-N-1076; FDA-2017-N-6162; FDA-2011-N-0510; FDA-2014-N-1414; FDA-2008-D-0610; FDA-2010-D-0073; FDA-2013-N-0080; FDA-2017-N-6397; FDA-2014-D-0313; FDA-2014-N-1030; and FDA-2014-D-1837] Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is publishing a list of information collections that have been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, *PRAStaff@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at *https://www.reginfo.gov/public/do/PRAMain.* An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Table 1—List of Information Collections Approved By OMB Title of collection OMB control No. Date approval expires Infant Formula Requirements 0910-0256 5/31/2021 Premarket Notification for a New Dietary Ingredient 0910-0330 5/31/2021 Regulations for In Vivo Radiopharmaceuticals Used for Diagnosis and Monitoring 0910-0409 5/31/2021 Guidance for Industry: Formal Dispute Resolution; Scientific and Technical Issues Related to Pharmaceutical Current Good Manufacturing Practice 0910-0563 5/31/2021 Requests for Inspection by an Accredited Person Under the Inspection for Accredited Persons Program 0910-0569 5/31/2021 Substances Prohibited from Use in Animal Food or Feed 0910-0627 5/31/2021 Class II Special Controls Guidance Document: Labeling for Natural Rubber Latex Condoms Classified Under 21 CFR 884.5300 0910-0633 5/31/2021 Guidance for Industry: Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic 0910-0701 5/31/2021 Guidance on Consultation Procedures: Foods Derived From New Plant Varieties 0910-0704 5/31/2021 Human Subject Protection; Acceptance of Data From Clinical Investigations for Medical Devices 0910-0741 5/31/2021 Food Labeling; Calorie Labeling of Articles of Food in Vending Machines and Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments 0910-0782 5/31/2021 Guidance for Industry, Researchers, Patient Groups, and Food and Drug Administration Staff on Meetings with the Office of Orphan Products Development 0910-0787 5/31/2021 Food Allergen Labeling and Reporting 0910-0792 5/31/2021 Transfer of a Premarket Notification Clearance 0910-0852 5/31/2021 Dated: June 13, 2018. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2018-13098 Filed 6-18-18; 8:45 am]
Connectionstraces to 2
Traces to 2 documents
Citation graph
cites case law
Cites 2Cited by 0 across 0 sources